Identification and staging of pancreatic tumours using computed tomography, endoscopic ultrasound and mangafodipir trisodium-enhanced magnetic resonance imaging

Australasian Radiology

Volumn 48, Issue 2, 2004, Pages 154-161

  Ramsay, Duncan ^a   Marshall, Martin ^a   Song, Swithin ^a   Zimmerman, Mathew ^a   Edmunds, Simon ^a   Yusoff, Ian ^a   Cullingford, Graham ^b   Fletcher, David ^b   Mendelson, Richard ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

Author keywords

Computed tomography; Endoscopic ultrasound; Magnetic resonance imaging; Pancreatic cancer

Indexed keywords

GADOLINIUM PENTETATE; IOVERSOL; MAGNAVIST; MANGAFODIPIR;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PANCREAS TUMOR; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE;

CONTRAST MEDIA; EDETIC ACID; ENDOSONOGRAPHY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PYRIDOXAL PHOSPHATE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3843059146     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2004.01277.x     Document Type: Article

References (50)

1. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349: 485-9.
2. Lillemore KD Current management of pancreatic carcinoma. Ann Surg 1995; 221: 133-48.
3. DiMagno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 1999; 117: 1464-84.
4. Bluemke M, Cameron J, Hruban R et al. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathological correlation. Radiology 1995; 197: 381-5.
5. Lu D, Reber H, Krasny R, Kadell B, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic phase, thin-section helical CT. AJR 1997; 168: 1439-43.
6. Nishiharu T, Yamashita Y, Abe Y et al. Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-holdfast MR imaging-ROC analysis. Radiology 1999; 212: 445-52.
7. Nakayama Y, Yamashita Y, Kadota M et al. Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathological results. J Comput Assist Tomogr 2001; 25: 337-42.
8. Andren-Sandberg A, Lindberg C, Lundstedt C, Ihse I. Computer tomography and laparoscopy in the assessment of the patient with pancreatic cancer. J Am Coll Surg 1998; 186: 35-40.
9. Zeman R, Cooper C, Zeiberg A et al. TNM staging of pancreatic carcinoma using helical CT. AJR 1997; 169: 459-64.
10. Hanninen E, Amthauer H, Hosten N et al. Prospective evaluation of pancreatic tumours: accuracy of MR imaging with MR cholangiopancreatography and angiography. Radiology 2002; 224: 34-41.
11. Ichikawa I, Haradome H, Hchiya J et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997; 202: 655-62.
12. Megibow A, Zhou X, Rotterdam H et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability. Report of the radiology diagnostic oncology group. Radiology 1995; 195: 327-32.
13. Muller M, Meyenburg C, Bertchinger P, Schaer R, Marincek B. Pancreatic tumours: evaluation with endoscopic US, CT and MR imaging. Radiology 1994; 190: 745-51.
14. Torres C, Lundby A, Sterud T, McGill S, Gordon P, Bjerknes H. MnDPDP for MR imaging of the liver. Results from the European phase III studies. Acta Radiol 1997; 38: 631-7.
15. Wang C. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas. Acta Radiol Suppl 1998; 415: 1-31.
16. Wang C, Ahlstrom H, Ekholm S et al. Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study. Acta Radiol 1997; 38: 643-9.
17. Kane P, Ayton V, Walters H et al. MnDPDP-enhanced MR imaging of the liver. Correlation with surgical findings. Acta Radiol 1997; 38: 650-54.
18. Schima W, Fugger R, Schober E. Diagnosis and staging of pancreatic cancer: comparison of mangafodipir trisodium-contrast enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR 2002; 179: 717-24.
19. Ahlstrom H, Gehl H. Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging. Acta Radiol 1997; 38: 623-5.
20. Diehl S, Lehmann K, Gaa J, McGill S, Hoffmann V, Georgi M. MR imaging of pancreatic lesions. Comparison of Manganese-DPDP and Gadolinium chelate. Invest Radiol 1999; 34: 589-95.
21. Gehl H, Urhahn R, Bohndorf K et al. Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience. Radiology 1993; 186: 795-8.
22. Romijn M, Stoker J, Casper H et al. MRI with mangafodopir Trisodium in the detection and staging of pancreatic cancer. J Magn Reson Imaging 2000; 12: 261-8.
23. Ahlstrom H, Gehl H. Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging. Acta Radiol 1997; 38: 660-64.
24. Mayo-Smith W, Schima W, Saini S, Slater G, McFarland E. Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium. AJR 1998; 170: 649-52.
25. Rosch T, Braig C, Gain T et al. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology 1992; 102: 188-99.
26. Palazzo L, Roseau G, Gayet B et al. Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy 1993; 25: 143-50.
27. Legmann P, Vignaux O, Dousset B et al. Pancreatic tumours: comparison of dual-phase helical CT and endoscopic sonography. AJR 1998; 170: 1315-22.
28. Gress FG, Hawes RH, Savides TJ et al. Role of EUS in the preoperative staging of pancreatic cancer: a large single-center experience. Gastrointest Endosc 1999; 50: 786-91.
29. Midwinter M, Beveridge C, Wilsdon J, Bennett M, Baudouin C, Charnley R. Correlation between spiral computer tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999; 86: 189-93.
30. Harrison J, Millikan K, Prinz R, Zaidi S. Endoscopic ultrasound for diagnosis and staging of pancreatic tumours. Am Surg 1999; 65: 659-64.
31. Ahmad NA, Lewis JD, Ginsberg GG, Rosato EF, Morris JB, Kochman ML. EUS in preoperative staging of pancreatic cancer. Gastrointest Endosc 2000; 52: 463-8.
32. Rosch T, Dittler HJ, Strobel K et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind revaluation of videotapes. Gastrointest Endosc 2000; 52: 469-77.
33. Akahoshi K, Chijiiwa Y, Nakano I et al. Diagnosis and staging of pancreatic cancer by endoscopic ultrasound. Br J Radiol 1998; 71: 492-6.
34. Yusoff I, Mendelson R, Edmunds S et al. Accuracy of endoscopic ultrasound in preoperative assessment of pancreatic malignancy. Abdom Imaging 2003; 28: 556-62.
35. Snady H, Bruckner H, Siegel J, Cooperman A, Neff R, Kiefer L. Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumours. Gastrointest Endosc 1994; 40: 326-33.
36. Catalano M, Sivak M, Bedford R et al. Observer variation and reproducibility of endoscopic ultrasonography. Gastrointest Endosc 1995; 41: 115-20.
37. Hommeyer S, Freent P, Crabo L. Carcinoma of the head of the pancreas: evaluation of the pancreaticoduodenal veins with dynamic CT-potential for improved accuracy in staging. Radiology 1995; 196: 233-8.
38. O'Malley M, Boland G, Wood B, Fernandez-del Castillo C, Warshaw A, Mueller P. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR 1999; 173: 1513-18.
39. Fleming I, Cooper J. Exocrine pancreas. In: Fleming I, Cooper J, Henson D et al. AJCC Cancer Staging Manual, 5th edn. Lippincott-Raven, Philadelphia, 1997; 121-4.
40. McNemar Q. Note of the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947; 12: 153-7.
41. Fischer U, Vosshenrich R, Horstman O et al. Preoperative local MRI-staging of patients with a suspected pancreastic mass. Eur Radiol 2002; 12: 296-303.
42. Trede M, Rumstadt B, Wendl E et al. Ultraradt Magnetic resonance imaging improves the staging of pancreatic tumours. Ann Surg 1997; 226: 393-407.
43. Valls C, Andia E, Sanchez A et al. Dual-phase helical CT of pancreatic adenocarcinoma. AJR 2002; 178: 821-6.
44. Oudkerk M, Torres C, Song B et al. Characterisation of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 2002; 223: 517-24.
45. Declore R, Rodriguez F, Forster J, Hermreck A, Thomas J. Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 1996; 172: 463-8.
46. Tio TL, Sie LH, Kallimanis G et al. Staging of ampullary and pancreatic carcinoma: comparison between endosonography and surgery. Gastrointest Endosc 1996; 44: 706-13.
47. Grimm H, Maydeo A, Soehendra N. Endoluminal ultrasound for the diagnosis and staging of pancreatic cancer. Baillieres Clin Gastroenterol 1990; 4: 869-88.
48. Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190: 745-51.
49. Rosch T, Dittler HJ, Strobel K et al. Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind revaluation of videotapes. Gastrointest Endosc 2000; 52: 469-77
50. Prokesch R, Chow L, Beaulieu C et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations - initial experience. Radiology 2002; 225: 759-65.